Login to Your Account



Financings Roundup

Synchroneuron Raises $6M for Movement Disorders Candidate

By Marie Powers
Staff Writer

Wednesday, February 8, 2012
Privately held Synchroneuron Inc. raised $6 million in a Series A financing from Morningside Ventures to advance a candidate targeting tardive dyskinesia (TD) and related movement disorders.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription